Annual Drug Patent Expirations for GAVRETO
Gavreto is a drug marketed by Blueprint Medicines and is included in one NDA. There is one patent protecting this drug.
This drug has twenty patent family members in nineteen countries.
The generic ingredient in GAVRETO is pralsetinib. Additional details are available on the pralsetinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
